Industry Events
EnglishFrançaisEspañol中文العربية
EventosNoticiasAnálisisOrganizadores
Servicios
  • Marketing de EventosPublica, promociona y haz crecer tus eventos ante una audiencia B2B global.
  • Comunicado de PrensaDistribuye anuncios oficiales a profesionales del sector en todo el mundo.
  • Promoción de Ponentes y ExpertosMuestra tu experiencia y consigue keynotes, paneles y masterclasses.
Suscribirse
Acceso PonentesPublicar su evento gratis
Industry Events

La plataforma de descubrimiento de eventos B2B más confiable del mundo. Conectamos a los profesionales del sector con las conferencias, exposiciones y cumbres que importan.

  • Industry Events
  • Noticias
  • Organizadores de eventos
  • Acerca de nosotros
  • Nuestros servicios
  • Organizador Premium
  • Event Pro
  • Conviértete en Ponente
  • Suscribirse
  • Términos
  • Privacidad

© 2026 Industry Events Worldwide. Todos los derechos reservados.

VF102.2.
  • Eventos
  • Noticias
  • Análisis
  • Cuenta
Industry Events
EnglishFrançaisEspañol中文العربية
EventosNoticiasAnálisisOrganizadores
Servicios
  • Marketing de EventosPublica, promociona y haz crecer tus eventos ante una audiencia B2B global.
  • Comunicado de PrensaDistribuye anuncios oficiales a profesionales del sector en todo el mundo.
  • Promoción de Ponentes y ExpertosMuestra tu experiencia y consigue keynotes, paneles y masterclasses.
Suscribirse
Acceso PonentesPublicar su evento gratis
  1. Inicio
  2. Noticias
  3. STAT+: Novartis’ experimental cardiovascular drug fails a pivotal study

STAT News

STAT+: Novartis’ experimental cardiovascular drug fails a pivotal study

A closely watched cardiovascular drug from Novartis failed in a pivotal study, the company said Friday, a major blow to the firm.

Continúe con el reportaje completo en el sitio web del editor.

Leer el artículo completo en STAT News
S

Por STAT News

4 September 2026|1 minuto de lectura
Compartir
Health Tech
STAT+: Novartis’ experimental cardiovascular drug fails a pivotal study
STAT+: Novartis’ experimental cardiovascular drug fails a pivotal study
Compartir
← Volver a IE News

¿Tiene noticias que compartir con el sector de eventos?

Envíe un comunicado de prensa o una noticia y llegue a miles de profesionales del sector de eventos.

Contáctenos→

Más en Health Tech

  • Opinion: Make infectious disease data boring again

    STAT News

    Opinion: Make infectious disease data boring again

    4 September 2026
  • STAT+: After failure of Angelman syndrome drug, experts see hope in other experimental therapies

    STAT News

    STAT+: After failure of Angelman syndrome drug, experts see hope in other experimental therapies

    4 September 2026
  • Opinion: The FDA removed the red tape around one of the best drugs for children with schizophrenia. But the fear remains

    STAT News

    Opinion: The FDA removed the red tape around one of the best drugs for children with schizophrenia. But the fear remains

    4 September 2026
  • STAT+: Top Boston hospitals clash over Medicare Advantage network after split

    STAT News

    STAT+: Top Boston hospitals clash over Medicare Advantage network after split

    4 September 2026
  • STAT+: FDA takes another look at botanical drugs

    STAT News

    STAT+: FDA takes another look at botanical drugs

    4 September 2026
  • STAT+: Fauci speaks, and writes

    STAT News

    STAT+: Fauci speaks, and writes

    3 September 2026

Perspectivas relacionadas

  • Advanced manufacturing and industrial AI

    Rare Earth Elements: The Invisible Engine of Modern Life

    11 Aug 202610 min read
  • Smart agriculture and food technology

    The Future of Food: Vertical & Indoor Farming Is Becoming a Serious Growth Industry

    Vertical farming cuts water use 90%, grows food anywhere, anytime—and with costs plummeting, it’s both a climate lifeline and a trillion-dollar investment bet.

    2 Aug 202610 min read
  • Precision medicine and longevity

    AI Series: Predictive HealthCare

    Predictive and Preventive medicine is quietly rewiring how care works. Here's what's changing, what's real, and how to get ahead of it.

    28 Jul 202614 min read
Browse all insights →

Eventos relacionados

  • Project Finance & Project Financial Modelling - Oct 2026

    19 Oct 2025
  • ADIHEX 2026 (Abu Dhabi International Hunting and Equestrian Exhibition)

    28 Aug 2026
    Abu Dhabi, United Arab Emirates
  • Common S3nse - Conference + Hackathon

    4 Sept 2026
    Amsterdam, Netherlands
  • INFRAME Expo 2026

    4 Sept 2026
    India
Ver todos los eventos→

Más de la redacción

  • HHS flip-flops on disability lawsuit

    HHS flip-flops on disability lawsuit

    3 September 2026
  • STAT+: OpenEvidence launches new family of AI models

    STAT+: OpenEvidence launches new family of AI models

    3 September 2026
  • ‘Tactical athletes’ get new guidance for cardiovascular fitness

    ‘Tactical athletes’ get new guidance for cardiovascular fitness

    3 September 2026
  • Why are drug overdose deaths declining?

    Why are drug overdose deaths declining?

    3 September 2026
Industry Events

La plataforma de descubrimiento de eventos B2B más confiable del mundo. Conectamos a los profesionales del sector con las conferencias, exposiciones y cumbres que importan.

  • Industry Events
  • Noticias
  • Organizadores de eventos
  • Acerca de nosotros
  • Nuestros servicios
  • Organizador Premium
  • Event Pro
  • Conviértete en Ponente
  • Suscribirse
  • Términos
  • Privacidad

© 2026 Industry Events Worldwide. Todos los derechos reservados.

VF102.2.